FindTrial
Sign In

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Buprenorphine Pharmacology Related to Addiction Treatment

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000239
Enrollment
0
Registered
1999-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2005-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-Related Disorders

Brief summary

The purpose of this study is to examine if chronic buprenorphine administration will generate supersensitivity to opiates.

Interventions

DRUGBuprenorphine

Sponsors

University of Vermont
CollaboratorOTHER
National Institute on Drug Abuse (NIDA)
Lead SponsorNIH

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Drug use—
Opioid agonist effects—
Opiate withdrawal—
Physiological changes in: pupil diameter, blood pressure, heart rate, respiration—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026